Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction

The aim of the study is to analyze the impact of the Siewert classification on the pathological complete response (pcR), pattern of failure, and general outcome of patients treated, by preoperative chemoradiotherapy and surgery for an gastroesophageal junction adenocarcinoma (OGJA). From 2000 to 200...

Full description

Saved in:
Bibliographic Details
Main Authors: Laurence Moureau-Zabotto, Eric Teissier, Didier Cowen, David Azria, Steve Ellis, Michel Resbeut
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2015/404203
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559753209839616
author Laurence Moureau-Zabotto
Eric Teissier
Didier Cowen
David Azria
Steve Ellis
Michel Resbeut
author_facet Laurence Moureau-Zabotto
Eric Teissier
Didier Cowen
David Azria
Steve Ellis
Michel Resbeut
author_sort Laurence Moureau-Zabotto
collection DOAJ
description The aim of the study is to analyze the impact of the Siewert classification on the pathological complete response (pcR), pattern of failure, and general outcome of patients treated, by preoperative chemoradiotherapy and surgery for an gastroesophageal junction adenocarcinoma (OGJA). From 2000 to 2008, the charts of 68 patients were retrospectively reviewed. Tumor staging reported was UST1/T2/T3/T4/unknown, respectively, n = 1/7/54/5/1 patients, and N0/N1/unknown, respectively, n = 9/58/1 patients. Patients received primary external-beam radiotherapy with concurrent chemotherapy followed by surgical resection (Siewert I: upper oesogastrectomy; Siewert II/III: total gastrectomy with lower oesophagectomy). Overall survival (OS), overall relapse rate (ORR), cumulative rate of local (CRLR), nodal (CRNR), and metastatic (CRMR) relapse, and their prognostic factors were retrospectively analyzed. Median follow-up was 77.5 months. Median OS was 41.7 ± 5.2 months. The 3-year ORR was 48%. Using univariate analysis ORR was significantly increased for patients with Siewert II/III compared to Siewert I tumors (27.3% versus 62%, p=0.047). Siewert I tumors had also statistically lower CRNR and CRMR compared to Siewert II/III tumors (0/9.1% versus 41.3/60.2% resp., p=0.012), despite an equivalent cumulative rate of local relapse and pathological complete response rate between the three groups. For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.
format Article
id doaj-art-332886d5406a457281240cb6b89742bc
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-332886d5406a457281240cb6b89742bc2025-02-03T01:29:16ZengWileyGastroenterology Research and Practice1687-61211687-630X2015-01-01201510.1155/2015/404203404203Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric JunctionLaurence Moureau-Zabotto0Eric Teissier1Didier Cowen2David Azria3Steve Ellis4Michel Resbeut5Department of Radiation Therapy, Institut Paoli Calmettes, 232 boulevard de Sainte Marguerite, 13009 Marseille, FranceAzurean Cancer Center, Mougins, FranceDepartment of Radiation Therapy, Timone Academic Hospital and North Academic Hospital, Marseille, FranceDepartment of Radiation Therapy, Val d’Aurelle Cancer Center, Montpellier, FranceCatalan Oncology Center, Perpignan, FranceDepartment of Radiation Therapy, Institut Paoli Calmettes, 232 boulevard de Sainte Marguerite, 13009 Marseille, FranceThe aim of the study is to analyze the impact of the Siewert classification on the pathological complete response (pcR), pattern of failure, and general outcome of patients treated, by preoperative chemoradiotherapy and surgery for an gastroesophageal junction adenocarcinoma (OGJA). From 2000 to 2008, the charts of 68 patients were retrospectively reviewed. Tumor staging reported was UST1/T2/T3/T4/unknown, respectively, n = 1/7/54/5/1 patients, and N0/N1/unknown, respectively, n = 9/58/1 patients. Patients received primary external-beam radiotherapy with concurrent chemotherapy followed by surgical resection (Siewert I: upper oesogastrectomy; Siewert II/III: total gastrectomy with lower oesophagectomy). Overall survival (OS), overall relapse rate (ORR), cumulative rate of local (CRLR), nodal (CRNR), and metastatic (CRMR) relapse, and their prognostic factors were retrospectively analyzed. Median follow-up was 77.5 months. Median OS was 41.7 ± 5.2 months. The 3-year ORR was 48%. Using univariate analysis ORR was significantly increased for patients with Siewert II/III compared to Siewert I tumors (27.3% versus 62%, p=0.047). Siewert I tumors had also statistically lower CRNR and CRMR compared to Siewert II/III tumors (0/9.1% versus 41.3/60.2% resp., p=0.012), despite an equivalent cumulative rate of local relapse and pathological complete response rate between the three groups. For OGJA treated with preoperative CRT and surgery, ORR and CRMR were lower for patients with Siewert I tumors in comparison with Siewert II/III tumors.http://dx.doi.org/10.1155/2015/404203
spellingShingle Laurence Moureau-Zabotto
Eric Teissier
Didier Cowen
David Azria
Steve Ellis
Michel Resbeut
Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
Gastroenterology Research and Practice
title Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
title_full Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
title_fullStr Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
title_full_unstemmed Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
title_short Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
title_sort impact of the siewert classification on the outcome of patients treated by preoperative chemoradiotherapy for a nonmetastatic adenocarcinoma of the oesophagogastric junction
url http://dx.doi.org/10.1155/2015/404203
work_keys_str_mv AT laurencemoureauzabotto impactofthesiewertclassificationontheoutcomeofpatientstreatedbypreoperativechemoradiotherapyforanonmetastaticadenocarcinomaoftheoesophagogastricjunction
AT ericteissier impactofthesiewertclassificationontheoutcomeofpatientstreatedbypreoperativechemoradiotherapyforanonmetastaticadenocarcinomaoftheoesophagogastricjunction
AT didiercowen impactofthesiewertclassificationontheoutcomeofpatientstreatedbypreoperativechemoradiotherapyforanonmetastaticadenocarcinomaoftheoesophagogastricjunction
AT davidazria impactofthesiewertclassificationontheoutcomeofpatientstreatedbypreoperativechemoradiotherapyforanonmetastaticadenocarcinomaoftheoesophagogastricjunction
AT steveellis impactofthesiewertclassificationontheoutcomeofpatientstreatedbypreoperativechemoradiotherapyforanonmetastaticadenocarcinomaoftheoesophagogastricjunction
AT michelresbeut impactofthesiewertclassificationontheoutcomeofpatientstreatedbypreoperativechemoradiotherapyforanonmetastaticadenocarcinomaoftheoesophagogastricjunction